Skip to main content
Back
Watch Compare

NewGenIvf Group Ltd

Data quality: 100%
Also listed as NIVFW NASDAQ
NIVF
NASDAQ Services Health Services
$2.04
▼ $0.10 (-4.77%)
Mkt Cap: 1.22 M
Price
$2.14
Mkt Cap
1.22 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

ROE of 77.23% indicates high profitability
Net margin of 209.02% shows strong profitability
Negative free cash flow of -11.06 M
P/E of 0.12 — trading at a low valuation
Capital efficient — spends only 2.86% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-13.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
77.23%
Above sector avg (-15.97%)
ROIC-68.73%
Net Margin209.02%
Op. Margin-226.95%

Safety

Debt / Equity
N/A
Current Ratio3.12
Interest Coverage-14.02

Valuation

PE (TTM|NTM|2027)
0.12 | 0.22 | 0.23
Above sector avg (-1.18)
P/B Ratio0.05
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (515 peers)
Metric Stock Sector Median
P/E 0.1 -1.2
P/B 0.1 1.4
ROE % 77.2 -16.0
Net Margin % 209.0 -18.7
Rev Growth 5Y % — 4.0
D/E — 0.4

Analyst Price Target

1 analyst
Hold
Current
$2.04
+44060.9%
Target
$900.00
$900.00
$900.00
$900.00
Forecast
Forward P/E 0.22
Forward EPS $9.34
EPS Growth (est.) +97.1%
Est. Revenue 180.40 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 $9.34
$9.34 – $9.34
 180.40 M 1
FY2026 $4.74
$4.74 – $4.74
 65.10 M 1

All Fundamental Metrics
Growth
Revenue Growth (1Y) -13.01% Revenue Growth (3Y) -4.07%
Earnings Growth (1Y) N/A Earnings Growth (3Y) 771.11%
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.73 M Net Income (TTM) 9.88 M
ROE 77.23% ROA 54.43%
Gross Margin 20.22% Operating Margin -226.95%
Net Margin 209.02% Free Cash Flow (TTM) -11.06 M
ROIC -68.73% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.12
Interest Coverage -14.02 Asset Turnover 0.26
Working Capital 5.02 M Tangible Book Value 5.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0.12 Forward P/E 0.22
P/B Ratio 0.05 P/S Ratio 0.26
PEG Ratio N/A Forward PEG 0.00
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0.01 Fwd Earnings Yield 454.55%
FCF Yield -909.12%
Market Cap 1.22 M Enterprise Value 458,059.0
Per Share
EPS (Diluted TTM) 3.04 Revenue / Share 8.31
FCF / Share -19.46 OCF / Share -19.22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2.86% FCF Conversion -111.96%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 4.73 M 5.43 M 5.14 M
Net Income 9.88 M -524,643.0 130,193.0
EPS (Diluted) 3.04 -0.64 0.18
Gross Profit 955,846.0 1.83 M 1.68 M
Operating Income -10.73 M -1.16 M 42,242.0
EBITDA — — —
R&D Expenses — — —
SG&A Expenses — — —
D&A 188,109.0 19,502.0 31,173.0
Interest Expense 765,177.0 765,177.0 46,179.0
Income Tax -486,706.0 -486,706.0 208,141.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 32.72 M 3.58 M 1.65 M
Total Liabilities 6.74 M 5.06 M 1.24 M
Shareholders' Equity 26.63 M -1.05 M 896,076.0
Total Debt — — —
Cash & Equivalents 758,621.0 457,740.0 54,104.0
Current Assets 7.38 M 3.17 M 1.20 M
Current Liabilities 2.37 M 2.72 M 1.12 M